Insulet Share Price

Insulet Share Price

NASDAQ: PODD | Mid Cap | Healthcare
$140.39
-$4.94 (-3.4%) Last updated on 19 Nov, 2026 | 01:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Insulet Stock Performance

Open
$144.37
Prev. Close
$145.33
Circuit Range
N/A
Day Range
$139.67 - $146.12
Year Range
$126.50 - $354.50
Volume
52,374
Average Traded
$142.61

Insulet Share Price Today

As of 19 November 2026, Insulet Corporation's share price is $140.39. The stock opened at $144.37, compared to its previous close of $145.33. During today's trading session, Insulet Corporation's share price traded between $139.67 and $146.12, with an average price of $142.89. Over the past 52 weeks, the stock has recorded a high of $354.50 and a low of $126.50. In terms of performance, Insulet Corporation's share price has declined by 3.20% over the last six months and is down 57.07% on a year-on-year basis.

Insulet Share Price Chart

Line chart of the Insulet price trend over the selected period. The price fell overall, ranging from 139.55 to 146.07, ending at 140.39.
$139.67$146.12
L
Show Current Price
H

Insulet Stock Fundamentals & Key Indicators

Market Cap
$9.88B
PE Ratio (TTM)
23.51
Dividend Yield
0.00%
EPS (TTM)
$6.18
Revenue (TTM)
$2.71T
Return On Equity (TTM)
27.15%
Profit Margin
9.12%
Debt to Equity
0.61
Quarterly Earnings Growth YoY
38.88%

Insulet Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$783.80$761.70$801.70$842.00
Net Profit$101.60$91.10$95.00$141.10
Net Profit Margin12.96%11.96%11.85%16.76%
Income ChangeN/A-10.33%4.28%48.53%

Insulet Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1305.30$1697.10$2071.60$2708.10
Net Profit$4.60$206.30$418.30$247.10
Net Profit Margin0.35%12.16%20.19%9.12%
Income ChangeN/A4384.78%102.76%-40.93%

Insulet Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets1276.41196.41005.3937.1
Current Assets1914.01891.31582.91314.0
Total Assets3190.43087.72588.22251.1
Non Current Liabilities995.11347.71404.31410.0
Current Liabilities680.1528.4451.2364.7
Total Liabilities1675.21876.11855.51774.7
Shareholders' Equity1515.21211.6732.7476.4

Insulet Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating569.3430.4145.8119.0
Investing-222.6-146.2-119.4-191.1
Financing-595.5-28.2-13.8-40.3

About Insulet

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.

Insulet Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$150.81
$140.24
-6.21%
Oct 2026
$132.01
$149.53
+14.53%
Sep 2026
$150.10
$130.56
-8.96%
Aug 2026
$169.50
$143.41
-13.25%
Jul 2026
$156.09
$165.32
+8.61%
Jun 2026
$146.52
$152.22
+4.96%
May 2026
$174.00
$145.03
-15.74%
Apr 2026
$210.55
$172.13
-17.99%
Mar 2026
$244.62
$209.89
-14.88%
Feb 2026
$258.17
$246.59
-3.59%
Jan 2026
$286.02
$255.78
-10.00%
Dec 2025
$324.90
$284.19
-13.09%

Insulet Share Price FAQs